Trial Profile
Telaprevir plus Ribavirin for the treatment Of acute Hepatitis C in HIV-infected patients - study.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Mar 2012
Price :
$35
*
At a glance
- Drugs Ribavirin (Primary) ; Telaprevir (Primary) ; Peginterferon alfa
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms PRO-HEP
- 09 Mar 2012 New trial record